According to the Zhitong Finance App, Jinhuo Pharmaceutical Group (01110.HK) announced results for the six months ended June 30, 2026. The group achieved revenue of 275 million yuan during the period, a decrease of 32% over the previous year; losses attributable to the company's owners were 5.224 million yuan, a decrease of 3.5% over the previous year; and the basic loss per share was 0.9 points.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.